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Abstract
Rationale:Medial medullary infarction accounts for less than 1% of brain infarctions, and medial medullary infarctions is very rarely
caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Patientconcerns:We report the case of a 76-year-old man at low risk of arteriosclerosis who presented with disorders on the left
side including gaze-evoked nystagmus, paralysis of the extremities, pyramidal signs, sensory disturbance, and dysesthesia. Brain
magnetic resonance imaging also showed right medial medullary infarction.
Diagnoses: Medial medullary infarction caused by ANCA-related vasculitis was diagnosed based on mild renal dysfunction and
high levels of blood leukocytes, C-reactive protein (CRP), and myeloperoxidase (MPO)-ANCA.
Interventions and outcomes: He underwent two 3-day courses of steroid pulse therapy involving daily 1000mg doses of
methylpredonine. He then received 30mg/day (0.5mg/kg/day) of prednisolone (PSL) without other immunosuppressants. Levels of
MPO-ANCA and the inﬂammatory marker CRP decreased rapidly a month after admission. Once MPO-ANCA became
undetectable, the PSL dose was carefully reduced to 10mg/day. To treat his paralysis, we provided rehabilitation with a Hybrid
Assistive Limb ﬁve times starting at a month post-onset. His Barthel index score rose from 45 to 70 points.
Lessons: Medullary infarction is mostly caused by arteriosclerosis and vertebral arterial dissection. When systemic inﬂammatory
ﬁndings are obtained, ANCA-associated vasculitis should be considered a potential cause, and steroid pulse therapy should be
promptly administered.
Abbreviations: ANCA = antineutrophil cytoplasmic antibody, CRP = C-reactive protein, CT = computed tomography, MPO =
myeloperoxidase, MRI = magnetic resonance imaging, PSL = prednisolone, s-IL2R = interleukin-2 receptor.
Keywords: ANCA-related vasculitis, hybrid assistive limb, medial medullary infarction, MPO-ANCA
1. Introduction brain infarctions), artery dissection (15%), small-vessel infarc-Medial medullary infarction accounts for <1% of brain
infarctions[1] and is usually caused by atherothrombotic brain
infarction. Other causes include large-vessel infarction (50% ofEditor: Raouf Hajji.
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1tion (13%), cardiac thrombosis (5%), and Moyamoya disease
(<1%).[2] In rare cases of antineutrophil cytoplasmic antibody
(ANCA)-associated vasculitis, the initial symptoms are those of
cerebral infarction, which is difﬁcult to distinguish from
atherothrombotic cerebral infarction, leading to possible treat-
ment delays. We report a case of medial medullary infarction
caused by ANCA-associated vasculitis that was effectively treated
with steroid pulse therapy.2. Case report
A 76-year-old man noticed bilateral edema in his lower legs and
livedo reticularis and a weight gain of 4kg 1 month before being
transferred to our hospital. Eleven days before the transfer, he
suddenly felt dizzy at work and became unable to walk. Because
weakness in the left extremities and dysarthria occurred
simultaneously, he visited a nearby hospital and was diagnosed
with a brainstem infarction using brain magnetic resonance
imaging (MRI). Because hypertension was noticed in a medical
appointment earlier in the year, he had been receiving oral
amlodipine (2.5mg/day), and his blood pressure was favorably
controlled. Although he received antiplatelet therapy (intrave-
nous infusion of ozagrel [160mg/day], aspirin [100mg/day], and
cilostazol [100mg/day]), left limb paralysis and dysarthria
progressed. In addition, his renal function deteriorated (creati-
Figure 1. Brain magnetic resonance imaging at 2 weeks after onset showed a
hyperintensity lesion in the right medial medulla oblongata on diffusion-
weighted imaging and T2-weighted imaging. No clear infarct enlargement or
suspicious new infarcts were observed in comparison with MRI scans taken at
the previous hospital. We observed nonspeciﬁc high-signal intensity lesions in
the deep white matter on T2-WI.
Yanagiha et al. Medicine (2017) 96:33 Medicinenine [Cre]: 1.3mg/dL), and a myeloperoxidase (MPO)-ANCA
test result was highly positive. Because cerebral infarction
associated with the vasculitis was suspected, he was therefore
transferred to our hospital,
In a physical examination on admission, he was alert, had mild
hypertension (146/84mmHg), and had a regular pulse (81beats/
min). In a neurologic examination, he exhibited gaze-evoked
nystagmus when looking to the left. He had dysarthria,
dysphagia, and an impaired gag reﬂex. He had bilateral Babinski
and Chaddock signs during extension, dysesthesia, and left-side
extremity disorders including paresis, enhanced tendon reﬂexes,
and impaired positional and tactile senses. He could sit upright
but could not stand or walk independently. Neither cerebellar
ataxia nor autonomic system dysfunction was observed.
Laboratory tests showed 20 to 99 red blood cells per high
power ﬁeld and 5 to 9 granular casts per whole ﬁeld in the urinary
sediment, leading us to suspect nephritis. We therefore ran
various serological tests to assess the likelihood of nephritis. The
white blood cell count was high (11,000cells/mL), and anemia
was observed (hemoglobin: 8.6g/dL). A coagulation test showed
a prolonged activated partial thromboplastin time (43.6s). Mild
hepatic dysfunction was observed. Glucose tolerance was
normal. Elevating C-reactive protein (CRP: 6.93mg/dL) and
normal procalcitonin (0.10mg/dL) showed systemic inﬂamma-
tion without any bacterial infections. The immunoglobulin levels
in the g-globulin fraction and among complement proteins were
normal. Antinuclear antibodies were not detected. Blood analysis
revealed reduced levels of anti-DNA antibodies (<4IU/mL) and
anti-proteinase 3-ANCA (<1.0U/mL) and a high level of MPO-
ANCA (130.0U/mL). The soluble interleukin-2 receptor (s-IL2R)
level was 981U/mL, and the rheumatoid factor level was 6U/mL.
Neither anti-Anti-Sjögren-syndrome-related antigen A nor anti-
gen B antibodies were detected, and complement protein levels
were within the normal range. Tumor marker levels were normal.
The absence of serological abnormalities disproved our suspicion
of nephritis and made us instead suspect a hepatitis B or C
infection. We next ran several tests to assess the likelihood of
hepatitis infection. The lack of any observed abnormalities led us
to reject the possibility of a hepatitis infection.
An analysis of cerebrospinal ﬂuid showed a cell count of 0cells/
mL, a protein concentration of 46mg/dL, a glucose concentration
of 62mg/dL (simultaneous blood glucose: 116mg/dL), and an s-
IL2R concentration of<50.0U/mL, all within normal ranges. No
abnormalities were observed in electrocardiograms or chest and
abdominal x-rays.
Brain MRI at 2 weeks after onset showed medial medullary
infarction in diffusion-weighted imaging and T2-weighted
imaging. When compared with MRI scans from the previous
hospital, there was no obvious infarct enlargement or new infarct
development (Fig. 1).
A carotid ultrasound did not show any clear plaque lesions on
either side. Contrast-enhanced chest computed tomography (CT)
did not show thickening or irregular width of the aortic vascular
wall. Although minor pleural effusion was detected, chest CT
revealed no lesion suggestive of vasculitis. From these ﬁndings,
we denied suspicion of the large-vessel and/or medium-vessel
vasculitis.
A bilateral limb nerve conduction study found no abnormali-
ties. A neurological examination revealed left-dominant paresis
of all four extremities, dysarthria, dysphagia, and enhanced
tendon reﬂexes of the left extremities andMRI revealed right-side
medial medullary infarction. Based on the detection of MPO-
ANCA and systemic inﬂammation that was not attributable to2infection, we strongly suspected ANCA-associated vasculitis, but
we could not perform a renal biopsy. We diagnosed cerebral
lesion-limited ANCA-associated vasculitis with medullary in-
farction as an initial symptom. In screening for risk factors,
carotid ultrasound imaging revealed no arteriosclerotic lesions,
and we considered atherothrombotic brain infarction highly
unlikely to be a risk factor, so the patient’s favorably controlled
hypertension was the only risk factor.
Because there was no adequate evidence to perform immuno-
therapy in patients with advanced age or in cases, such as ours,
without lesions in other organs, we referred to Japanese
guidelines,[3] and chose steroid pulse therapy. We performed 2
courses of steroid pulse therapy on post-onset day 12 and
prescribed 30mg of orally administered prednisolone (PSL) for
posttreatment. The inﬂammatory response (CRP >6mg/dL)
rapidly declined, and the MPO-ANCA level gradually decreased.
PSL was continued at 30mg/day until the MPO-ANCA and CRP
level decreased to <10U/mL and <0.03mg/dL, respectively. On
post-onset day 43, both MPO-ANCA and CRP levels had
decreased.
Activities of daily living improved through rehabilitation. We
performed gait training with a hybrid assistive limb (HAL) 5
times beginning a month after onset.[4] The patient’s Barthel
Table 1
Reported cases of the ANCA-related vasculitis that presented medullary infarction.
Reports Age/sex Lesion Affected organ Onset of medullary infarction ANCA antibody titer Therapy
Chen et al[8] 72 M Medial medullary Renal; renal biopsy (+) One month before renal
dysfunction
P-ANCA; 788U/mL PE 4 times, Steroid
pulse Tx+ IVCY
Tarachenko et al[9] 41 M Medial medullary Renal; renal biopsy (+) One week before renal
dysfunction
C-ANCA; 100U/mL PE 5 times, Steroid
pulse Tx+ IVCY
Ozkul et al[10] 55 F Lateral medullary Auditory nerve, retina,
lung; Nerve biopsy (+)
One day before fever P-ANCA; 87.5U/mL Steroid pulse Tx,
PSL 80mg+ IVCY
Bares et al[11] 52 F Lateral medullary Renal; renal biopsy (+) Three month before renal
dysfunction
C-ANCA; 320 times PSL+ IVCY
Fauset et al[12] 49 M Lateral medullary Lung, renal, peripheral
nerve
One month after peripheral neurologic
symptoms
C-ANCA; 160 times Steroid pulse Tx,
PSL 125mg+ IVCY
Present case 76 M Medial medullary Renal Presenting symptom P-ANCA; 130U/mL Steroid pulse Tx,
PSL 30mg
P-ANCA (= MPO-ANCA)=perinuclear antineutrophil cytoplasm autoantibodies, C-ANCA(= PR3-ANCA)= cytoplasmic antineutrophil cytoplasm autoantibodies, PE=plasma exchange, PSL=prednisolone,
IVCY= intermittent pulse intravenous cyclophosphamide therapy.
Yanagiha et al. Medicine (2017) 96:33 www.md-journal.comindex score improved from 35 at admission to 45 points before
HAL training and 70 points after completion of the training.
Although the patient still experienced distal-dominant muscle
weakness, impaired sensation (impaired deep sensation and
mildly impaired superﬁcial sensation), and left femur-dominant
dysesthesia, he became able to walk independently using a walker
and was transferred to another hospital for further rehabilitation.
Our case report was waived from the ethical approval or
institutional review board of University of Tsukuba hospital,
based upon their policy to review all intervention and
observational study except for a case report. Written informed
consent was obtained from both patients for the publication of
this manuscript and accompanying images.3. Discussion
Primary vasculitis is classiﬁed into large-vessel, medium-vessel,
and small-vessel types. In small-vessel vasculitis, lesions are
present in the intraparenchymal small vessels such as small
arteries, arterioles, capillaries, and venulae. Cases are classiﬁed
into immune complex-mediated and nonimmune complex-
mediated groups. Nonimmune complex-mediated vasculitis
includes ANCA-associated vasculitis, a disease group so-called
because they share ANCAs as common disease markers. In 2012,
the Chapel Hill Consensus Conference[5] renamed and reclassi-
ﬁed the subclasses of ANCA-associated vasculitis into micro-
scopic polyangiitis, granulomatosis with polyangiitis, and
eosinophilic granulomatosis with polyangiitis. Although the
common sites and mechanisms of cerebral infarction caused by
ANCA-associated vasculitis have not been fully elucidated,
Reichart et al,[6] working before microscopic polyangiitis was
established as a disease concept, observed infarcts in the deep
white matter of the perforator region near a lacunar infarct in
patients with polyarteritis nodosa.
Concerning the differential diagnoses of our case, we could
exclude the diagnoses of IgA vasculitis and secondary vasculitis
associated with collagen disease from the patient’s medical
history and blood ﬁndings, including autoantibodies. A diagnosis
of polyarteritis nodosa was unlikely because there the patient
presented no myalgia or arthralgia, and was ANCA-positive.
Because there were no eye manifestations, erythema nodosum,
oral aphtha, or pubic region ulcer, Behcet disease was excluded.
PR3-ANCA was not detected, and there were no nose and ear3symptoms, including sinusitis or otitismedia, and vasculitis lesions
on chest CT; therefore, granulomatosis with polyangiitis was
excluded, too. Finally, because he does not have asthma, allergic
rhinitis, eosinophilia, or IgE elevation until now, a diagnosis of
eosinophilic granulomatosis with polyangitis was unlikely.
Because CRP and MPO-ANCA titer moved parallel to the
disease activity, and skin lesions associated with livedo reticulata
and renal dysfunction were observed, we diagnosed this case as
cerebral lesion-limited ANCA-associated vasculitis with the
exclusion of other possible vasculitis.
There are some limitations about the diagnosis of our case.
First, the diagnosis was not conﬁrmed pathologically; second, no
abnormalities were found in main target organs, such as the
kidneys or lungs.
Medullary infarction is less common than cerebral infarction.
Lateral medullary infarction accounts for no >2.5% of all
reported cerebral infarction cases, and medial medullary
infarction accounts for no >1%.[1] In addition, Toyoda et al[7]
reported observing 11 cases (0.52%) of medullary infarction
among 2130 brain infarction cases. The risk factors for medial
medullary syndrome (MMS) and lateral medullary syndrome
(LMS)[1,2] include hypertension (seen in 64%–89% of MMS
patients and 75% of LMS patients, respectively), diabetes
(25%–27% and 37%, respectively), recent smoking history
(6.8%–25% and 25%, respectively), and dyslipidemia (20% and
12%, respectively). Vasculitis is an extremely rare cause.
Only 5 cases of ANCA-associated vasculitis with medullary
infarction have been previously reported (Table 1).[8–12] The
patients in these cases were slightly younger (range: 41–72 years)
than ours. The lesion sites included the medial (n = 2) and lateral
(n=3) parts of the medulla oblongata. Except for nonspeciﬁc
symptoms such as fever, medullary infarction was the initial
symptom in most cases, as in ours. In all the patients with renal
dysfunction symptoms, these occurred or rapidly progressed after
the infarction developed. All patients received strong immuno-
therapy combined with steroid and cyclophosphamide (CY)
treatment, which resulted in favorable outcomes for all except
one with severe renal dysfunction.
Methotrexate or mycophenolate mofetil with glucocorticoid is
recommended as the standard therapies for ANCA-associated
vasculitis.[13] As shown in the Table 1, CY and plasma exchange
were combined with steroids in cases of medullary infarction
caused by ANCA-associated vasculitis with previous renal and/or
follow-up, randomized, controlled study. NeuroRehabilitation
Yanagiha et al. Medicine (2017) 96:33 Medicinelung involvement. However, there are 2 reports of ANCA-
associated vasculitis causing an isolated (without previous renal
and/or lung involvement) cerebrovascular lesion, which was
treated with steroid therapy alone.[14,15] As our patient was an
elderly patient lacking severe lesions in other organs, we followed
the Japanese guidelines[3] and administered steroids alone, thus
obtaining a successful outcome.
4. Conclusion
When systemic inﬂammation is observed in cases of medullary
infarction, ANCA-associated vasculitis should be considered a
potential cause, and steroid pulse therapy should be promptly
administered.Acknowledgement
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